Pre-eclampsia is a common disorder that particularly affects first pregnancies. The clinical
presentation is highly variable but hypertension and proteinuria are usually seen. These …

Placental dysfunction underlies a spectrum of perinatal pathologies, including preeclampsia
and fetal growth restriction. Angiogenesis-related factors, including sFlt-1 (soluble fms-like …

Preeclampsia is a pregnancy-specific syndrome with multisystem involvement which leads
to foetal, neonatal, and maternal morbidity and mortality. This syndrome is characterized by …

Placental insufficiency and adipose tissue dysregulation are postulated to play key roles in
the pathophysiology of both pre-eclampsia (PE) and gestational diabetes mellitus (GDM). A …

Pre‐eclampsia (PE) is characterized by placental and maternal endothelial dysfunction, and
associated with fetal growth restriction (FGR), placental abruption, preterm delivery and …

Background Preeclampsia is a disease specific to pregnancy that can cause severe
maternal and foetal morbidity and mortality. Early identification of women at higher risk for …

Objectives To identify maternal plasma protein markers for early preeclampsia (delivery< 34
weeks of gestation) and to determine whether the prediction performance is affected by …

Background Late-onset preeclampsia is the most prevalent phenotype of this syndrome;
nevertheless, only a few biomarkers for its early diagnosis have been reported. We sought to …

Objective There is a lack of evidence on the usage of the quality assessment tool‐the Risk
Of Bias In Nonrandomized Studies‐of Interventions (ROBINS‐I). This article aimed to …

Preeclampsia (PE) is a major complication of pregnancy with an incidence rate of 2-8% and
is a leading cause of maternal mortality and morbidity. The various consequences of severe …